Levobunolol
From Wikipedia, the free encyclopedia
(Redirected from Bunolol)
![]() |
|
Clinical data | |
---|---|
Trade names | Betagan |
AHFS/Drugs.com | Monograph |
MedlinePlus | a686011 |
Pregnancy category |
|
Routes of administration |
Topical (eye drops) |
ATC code | S01ED03 (WHO) |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Biological half-life | 20 hours |
Identifiers | |
CAS Number | 47141-42-4 ![]() |
PubChem | CID 39468 |
IUPHAR/BPS | 570 |
DrugBank | DB01210 ![]() |
ChemSpider | 36089 ![]() |
UNII | G6317AOI7K ![]() |
KEGG | D08115 ![]() |
ChEBI | CHEBI:6438 ![]() |
ChEMBL | CHEMBL1201237 ![]() |
Chemical and physical data | |
Systematic (IUPAC) name: (S)-5-{[3-(tert-Butylamino)-2-hydroxypropyl]oxy}-3,4-dihydronaphthalen-1(2H)-one
|
|
3D model (Jmol) | Interactive image |
Formula | C17H25NO3 |
Molar mass | 291.385 g/mol |
|
|
|
|
![]() ![]() |
Levobunolol (AK-Beta, Liquifilm, Betegan) is a non-selective beta blocker. It is used topically to manage glaucoma.
References[edit]
- Ishibashi T, Yokoi N, Kinoshita S (2003). "Comparison of the effects of topical levobunolol and timolol solution on the human ocular surface.". Cornea. 22 (8): 709–15. doi:10.1097/00003226-200311000-00001. PMID 14576520.
- Ogasawara H, Yoshida A, Fujio N, Konno S, Ishiko S (1999). "[Effect of topical levobunolol on retinal, optic nerve head, and choroidal circulation in normal volunteers]". Nippon Ganka Gakkai Zasshi. 103 (7): 544–50. PMID 10443129.
- Leung M, Grunwald J (1997). "Short-term effects of topical levobunolol on the human retinal circulation.". Eye. 11 (3): 371–6. doi:10.1038/eye.1997.78. PMID 9373479.
![]() |
This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |